✦ LIBER ✦

Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab

✍ Scribed by Heiduschka, Gregor; Grah, Anja; Oberndorfer, Felicitas; Seemann, Rudolf; Kranz, Alexander; Kornek, Gabriela; Wrba, Fritz; Thurnher, Dietmar; Selzer, Edgar

Book ID: 121858687
Publisher: Springer
Year: 2014
Tongue: German
Weight: 336 KB
Volume: 190
Category: Article
ISSN: 0179-7158
DOI: 10.1007/s00066-014-0652-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence of dermatitis in head and neck

Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab

✍ Edgar Selzer; Susanne Liederer; Christiane Lemaire; Gerhard Kren; Dejan Radonjic 📂 Article 📅 2011 🏛 Springer 🌐 German ⚖ 240 KB

The Prognostic Significance of p16 in Pa

The Prognostic Significance of p16 in Patients with Locoregionally Advanced Head and Neck Cancer Treated with Concurrent 5-Fluorouracil, Hydroxyurea, Cetuximab, and IMRT

✍ Lau, K.; Tong, C.C.L.; Rivera, M.; Packer, S.H.; Cannan, D.; Teng, M.S.; Sikora, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

p53 and P-glycoprotein expression are si

p53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy

✍ Warnakulasuriya, Saman; Jia, Chaoying; Johnson, Newell; Houghton, Joan 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

The development of biological markers of response to chemo-and radiotherapy to judge bene®t to risk ratios for toxic treatments is still at an experimental stage. Tumour cell death is largely by apoptosis and the p53 gene has a major in¯uence on this. P-glycoprotein (P-gp) accumulation has been corr

Enhanced toxicity with concurrent cetuxi

Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer

✍ David I. Pryor; Sandro V. Porceddu; Bryan H. Burmeister; Alex Guminski; Damien B 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Do all patients with head and neck cance

Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?

✍ Jesper Grau Eriksen; Pernille Lassen; Jens Overgaard 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 186 KB

Quality of life in head and neck cancer

Quality of life in head and neck cancer patients being treated with cetuximab therapy

✍ Caryn Scheinberg Andrews 📂 Article 📅 2006 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 63 KB